These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 4022138

  • 1. On the reversibility of reversible MAO inhibitors.
    Waldmeier PC.
    Naunyn Schmiedebergs Arch Pharmacol; 1985 May; 329(3):305-10. PubMed ID: 4022138
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Enhancement of 5-HT-induced anorexia: a test of the reversibility of monoamine oxidase inhibitors.
    Fletcher PJ, Yu PH.
    Psychopharmacology (Berl); 1989 May; 98(2):265-8. PubMed ID: 2502797
    [Abstract] [Full Text] [Related]

  • 4. Reversibility of the interaction of CGP 11305 A with MAO A in vivo.
    Waldmeier PC, Feldtrauer JJ, Stoecklin K, Paul E.
    Eur J Pharmacol; 1983 Oct 14; 94(1-2):101-8. PubMed ID: 6197309
    [Abstract] [Full Text] [Related]

  • 5. Short-acting novel MAO inhibitors: in vitro evidence for the reversibility of MAO inhibition by moclobemide and Ro 16-6491.
    Keller HH, Kettler R, Keller G, Da Prada M.
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Jan 14; 335(1):12-20. PubMed ID: 3574489
    [Abstract] [Full Text] [Related]

  • 6. Monoamine oxidase-inhibiting properties of SR 95191, a new pyridazine derivative, in the rat: evidence for selective and reversible inhibition of monoamine oxidase type A in vivo but not in vitro.
    Kan JP, Steinberg R, Leclercq J, Worms P, Biziere K.
    J Neurochem; 1988 Apr 14; 50(4):1137-44. PubMed ID: 3346672
    [Abstract] [Full Text] [Related]

  • 7. Comparison of monoamine oxidase-A inhibition by moclobemide in vitro and ex vivo in rats.
    Kettler R, Da Prada M, Burkard WP.
    Acta Psychiatr Scand Suppl; 1990 Apr 14; 360():101-2. PubMed ID: 2248058
    [Abstract] [Full Text] [Related]

  • 8. Selective inhibition by amiflamine of monoamine oxidase type A in rat brain, liver and duodenum.
    Ask AL.
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Aug 14; 327(1):56-63. PubMed ID: 6493351
    [Abstract] [Full Text] [Related]

  • 9. The metabolism of dopamine by both forms of monoamine oxidase in the rat brain and its inhibition by cimoxatone.
    Fowler CJ, Benedetti MS.
    J Neurochem; 1983 Jun 14; 40(6):1534-41. PubMed ID: 6406646
    [Abstract] [Full Text] [Related]

  • 10. Monoamine oxidase-A inhibitors and dopamine metabolism in rat caudatus: evidence that an increased cytosolic level of dopamine displaces reversible monoamine oxidase-A inhibitors in vivo.
    Colzi A, D'Agostini F, Cesura AM, Borroni E, Da Prada M.
    J Pharmacol Exp Ther; 1993 Apr 14; 265(1):103-11. PubMed ID: 8473998
    [Abstract] [Full Text] [Related]

  • 11. Effect of moclobemide on rat brain monoamine oxidase A and B: comparison with harmaline and clorgyline.
    Gerardy J.
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jul 14; 18(4):793-802. PubMed ID: 7938567
    [Abstract] [Full Text] [Related]

  • 12. Neurochemical profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A.
    Da Prada M, Kettler R, Keller HH, Burkard WP, Muggli-Maniglio D, Haefely WE.
    J Pharmacol Exp Ther; 1989 Jan 14; 248(1):400-14. PubMed ID: 2783611
    [Abstract] [Full Text] [Related]

  • 13. [Comparison of the new MAO-A inhibitors moclobemide, brofaromine and toloxatone with tranylcypromine in an animal experiment: significance for clinical practice].
    Da Prada M, Keller HH, Kettler R.
    Psychiatr Prax; 1989 Aug 14; 16 Suppl 1():18-24. PubMed ID: 2587673
    [Abstract] [Full Text] [Related]

  • 14. Deamination of norepinephrine, dopamine, and serotonin by type A monoamine oxidase in discrete regions of the rat brain and inhibition by RS-8359.
    Kumagae Y, Matsui Y, Iwata N.
    Jpn J Pharmacol; 1991 Jan 14; 55(1):121-8. PubMed ID: 1904113
    [Abstract] [Full Text] [Related]

  • 15. Potentiation of tyramine pressor responses in conscious rats by reversible inhibitors of monoamine oxidase.
    Finberg JP, Youdim MB.
    J Neural Transm Suppl; 1988 Jan 14; 26():11-6. PubMed ID: 3162950
    [Abstract] [Full Text] [Related]

  • 16. Effect of selective and reversible MAO inhibitors on dopamine outflow in rat striatum: a microdialysis study.
    Colzi A, d'Agostini F, Kettler R, Borroni E, Da Prada M.
    J Neural Transm Suppl; 1990 Jan 14; 32():79-84. PubMed ID: 2089114
    [Abstract] [Full Text] [Related]

  • 17. The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors.
    Alemany R, Olmos G, García-Sevilla JA.
    Br J Pharmacol; 1995 Feb 14; 114(4):837-45. PubMed ID: 7773544
    [Abstract] [Full Text] [Related]

  • 18. Preclinical profiles of the novel reversible MAO-A inhibitors, moclobemide and brofaromine, in comparison with irreversible MAO inhibitors.
    Da Prada M, Kettler R, Keller HH, Burkard WP, Haefely WE.
    J Neural Transm Suppl; 1989 Feb 14; 28():5-20. PubMed ID: 2677242
    [Abstract] [Full Text] [Related]

  • 19. Brain microdialysis in rats: a technique to reveal competition in vivo between endogenous dopamine and moclobemide, a RIMA antidepressant.
    Colzi A, d'Agostini F, Cesura AM, Da Prada M.
    Psychopharmacology (Berl); 1992 Feb 14; 106 Suppl():S17-20. PubMed ID: 1546133
    [Abstract] [Full Text] [Related]

  • 20. Brain dialysis: in vivo metabolism of dopamine and serotonin by monoamine oxidase A but not B in the striatum of unrestrained rats.
    Kato T, Dong B, Ishii K, Kinemuchi H.
    J Neurochem; 1986 Apr 14; 46(4):1277-82. PubMed ID: 2419508
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.